PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

JAMA

2023-10-05
(Press-News.org)

About The Study: This study found that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease. Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes. 

Authors: Mahyar Etminan, Pharm.D., M.Sc., of the University of British Columbia in Vancouver, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.19574)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.19574?guestAccessKey=31a6dd82-d1ee-46d6-b95e-e4ef621c2ddf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100523

 

END



ELSE PRESS RELEASES FROM THIS DATE:

UK study shows hybrid closed-loop technology improved maternal glucose levels during pregnancy complicated by type 1 diabetes

2023-10-05
For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomised trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October). Despite better systems for monitoring blood sugars and delivering insulin, hormonal changes and altered eating patterns during pregnancy mean that ...

Successful morphing of inorganic perovskites without damaging their functional properties

Successful morphing of inorganic perovskites without damaging their functional properties
2023-10-05
A research team co-led by scholars from City University of Hong Kong (CityU) has successfully morphed all-inorganic perovskites at room temperature without compromising their functional properties. Their findings demonstrate the potential of this class of semiconductors for manufacturing next-generation deformable electronics and energy systems in the future. All-inorganic lead halide perovskites are becoming increasingly important semiconducting materials in energy conversion and optoelectronics because of their outstanding performance and enhanced environmental stability. “However, unlike metal ...

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area
2023-10-05
HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the launch of Texas Health Equity Alliance for Breast Cancer (THEAL), a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women.  THEAL builds upon the expertise of MD Anderson’s Department of Health Disparities Research in addressing the determinants of cancer disparities while leveraging the cancer prevention and control platform’s experience in leading cross-sector collaboratives ...

In checking chess’s gender bias, researchers find parents and mentors shortchange girls’ potential

2023-10-05
“The Queen’s Gambit” miniseries portrayed the life of a fictional chess prodigy, Beth Harmon, who is continuously underestimated in male-dominated competitions. A team of New York University psychology researchers has now found some “real-life” evidence of what Harmon faced as a younger player: Parents and coaches of youth chess players peg the highest potential rating of girl players to be lower than that of boy players. Moreover, the study’s authors, who included Jennifer Shahade, a two-time US Women’s Chess champion, found ...

Female chess players may experience gender bias from parents, mentors

2023-10-05
Young female chess players often face gender bias both in the male-dominated chess world and among parents and mentors who believe girls have less potential to succeed in chess than boys, according to research published by the American Psychological Association.   “It’s disheartening to see young female players’ potential downgraded, even by the people who are closest to them, like their parents and coaches,” said lead researcher Sophie Arnold, a doctoral student at New York University.  The study, which was published online in the Journal of Experimental Psychology: General, presents what the researchers say is the first large-scale ...

US cancer centers continue to see chemotherapy shortages, according to update from NCCN

2023-10-05
PLYMOUTH MEETING, PA [October 5, 2023] — The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has released a follow-up survey on the ongoing chemotherapy shortages: 72% of the centers surveyed continue to experience a shortage of carboplatin and 59% are still seeing a shortage of cisplatin. Overall, 86% of centers surveyed reported experiencing a shortage of at least one type of anti-cancer drug. View the updated survey results at NCCN.org/platinum-update. The NCCN Best Practices Committee originally shared survey results ...

Announcing 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty

Announcing 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty
2023-10-05
NEW YORK, NY and SANTA BARBARA, CA – The American Federation for Aging Research (AFAR) and the Glenn Foundation for Medical Research are pleased to announce the 2023 Glenn Foundation for Medical Research and AFAR Research Grants for Junior Faculty recipients. The Research Grant for Junior Faculty provides an early career investigator with up to $150,000 for one to two ...

UNIST student startup sets new global standard for companion animal pet registration

UNIST student startup sets new global standard for companion animal pet registration
2023-10-05
Pireco Co., Ltd., a student-led venture company of UNIST, has accomplished a remarkable feat in establishing an international standard for their multi-biometrics identification solution designed for companion animals. This groundbreaking solution simplifies the process of accurately identifying and registering companion animals by simply scanning the distinctive patterns of ridges and creases on their noses using smartphones. The advent of this pioneering technology sets the stage for global registration ...

How much are you willing to pay for a product or service? It depends on your other options and the given context

2023-10-05
Researchers from Concordia University and Northwestern University published a new Journal of Marketing study that presents the Comparative Method of Valuation as a more accurate way to measure customers’ willingness to pay for a product or service. The study, forthcoming in the Journal of Marketing, is titled “Measuring Willingness to Pay: A Comparative Method of Valuation” and is authored by Sharlene He, Eric T. Anderson, and Derek D. Rucker. At the grocery store, a customer may be willing to pay $18 for a bottle of Riesling when comparing it to a $15 bottle ...

Alliance for Clinical Trials in Oncology study shows promise for patients with muscle-invasive urothelial carcinoma

Alliance for Clinical Trials in Oncology study shows promise for patients with muscle-invasive urothelial carcinoma
2023-10-05
The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive urothelial carcinoma (MIUC) and locally advanced urothelial carcinoma. At a pre-specified interim analysis review, pembrolizumab demonstrated a statistically significant and clinically meaningful ...

LAST 30 PRESS RELEASES:

Women’s brain regions may lose ability to synchronize after sexual assault

Quitting smoking, even late in life, linked to slower cognitive decline

Critical raw materials are a vital new currency; Europe’s e-waste is the vault

Anesthesiologist-led care helps hip-fracture patients get to surgery faster, with fewer complications

Two-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine

Excessive daytime sleepiness may raise risk of cognitive problems after surgery

Flipping the switch on sperm motility offers new hope for male infertility

Twisting sound: Scientists discover a new way to control mechanical vibrations in metamaterial

Drip by drip: The hidden blueprint for stalagmite growth

mRNA therapy restores sperm production and fertility in mice

New way to weaken cancer cells could supercharge prostate cancer treatment

How sound—but not touch—shapes rhythm in the brain

Exploring the therapeutic potential of hypothermia

Research alert: Bioengineering breathes new life into failed cancer treatment

AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence

Large genetic study links cannabis use to psychiatric, cognitive and physical health

Social media use trajectories and cognitive performance in adolescents

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults 

AI models predict sepsis in children, allow preemptive care

Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes

Antenatal corticosteroids and infectious diseases throughout childhood

New lab-grown human embryo model produces blood cells

Life after near death: Research reveals how to improve support for near-death experiencers

Illinois Chat is launched for campus community

FAU receives $3M federal grant to prevent substance use in at-risk youth

New report shows action to improve gender equity linked to career gains and better business performance

Kiwis could help manage chronic constipation

Breast, lung, and bladder cancer phase 3 trials led by Dana-Farber presented at ESMO Congress 2025

New open-source software allows for efficient 3D printing with multiple materials

Decoding the secrets of ‘chemo brain’

[Press-News.org] Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss
JAMA